Takao Minakata Selected Research

Enzymes

12/2018

Thymidine phosphorylase affects clinical outcome following surgery and mRNA expression levels of four key enzymes for 5-fluorouracil metabolism in patients with stage I and II non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takao Minakata Research Topics

Disease

2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 12/2018
1	Lymphangioma (Cavernous Lymphangioma) 11/2020
1	Cysts 11/2020
1	Granuloma 01/2020
1	Adenocarcinoma 12/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018
1	Neoplasms (Cancer) 12/2018
1	Papilloma (Papillomatosis) 06/2018
1	Adenocarcinoma of Lung 02/2018
1	Abscess 03/2017
1	Thymoma (Thymic Carcinoma) 12/2014
1	Necrosis 12/2014

Drug/Important Bio-Agent (IBA)

1	InterferonsIBA 01/2020
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 12/2018
1	EnzymesIBA 12/2018
1	Fluorouracil (Carac)FDA LinkGeneric 12/2018
1	Orotate PhosphoribosyltransferaseIBA 12/2018
1	Messenger RNA (mRNA)IBA 12/2018
1	Thymidine PhosphorylaseIBA 12/2018
1	Thymidylate SynthaseIBA 12/2018
1	squamous cell carcinoma-related antigenIBA 06/2018
1	antigen CYFRA21.1IBA 12/2014

Therapy/Procedure

1	Debridement 11/2020
1	Chest Tubes (Chest Tube) 11/2020
1	Drug Therapy (Chemotherapy) 12/2018
1	Lymph Node Excision (Lymph Node Dissection) 02/2018
1	Curettage 03/2017
1	Tracheotomy 03/2017